Literature DB >> 12790948

Detection of lymph node metastases in colorectal carcinoma.

S T O'Dwyer1, N Y Haboubi, J S Johnson, R Gardy.   

Abstract

The detection of lymph node metastases is the single most important prognostic factor for patients with colorectal cancer. This review outlines the difficulties and methods of detecting positive lymph node metastases in this disease. An outline of traditional diagnostic methods including preoperative ultrasound and cross sectional imaging techniques are evaluated alongside newer modalities including immunoscintography and PET scanning and intraoperative radioguided imaging. Pathological methods of detecting positive nodal disease using standard histopathological staging, enhanced lymph node harvesting and determination of micrometastases are also discussed.

Entities:  

Year:  2001        PMID: 12790948     DOI: 10.1046/j.1463-1318.2001.00251.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  4 in total

1.  Lymph node harvest in colon and rectal cancer: Current considerations.

Authors:  James R McDonald; Andrew G Renehan; Sarah T O'Dwyer; Najib Y Haboubi
Journal:  World J Gastrointest Surg       Date:  2012-01-27

2.  Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer.

Authors:  Jae Young Kwak; Jae Seung Kim; Hye Jin Kim; Hyun Kwon Ha; Chang Sik Yu; Jin Cheon Kim
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

3.  Tumor micrometastases in mesorectal lymph nodes and their clinical significance in patients with rectal caner.

Authors:  Yang-Chun Zheng; Yu-Ying Tang; Zong-Guang Zhou; Li Li; Tian-Cai Wang; Yi-Ling Deng; Dai-Yun Chen; Wei-Ping Liu
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

4.  Preoperative serum levels of serum VEGF-C is associated with distant metastasis in colorectal cancer patients.

Authors:  Andrew A Alabi; Aravind Suppiah; Leigh A Madden; John R Monson; John Greenman
Journal:  Int J Colorectal Dis       Date:  2008-12-16       Impact factor: 2.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.